Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic effect of sildenafil in severe mitral stenosis with reactive pulmonary hypertension undergoing mitral valve replacement
IRCT2014072818625N1Phase 3Completed
- Sponsor
- Tehran Heart Center
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in mitral stenosis (MS) and pulmonary hypertension (PH), sponsored by Tehran Heart Center. Started Sep 2014; status: completed.
02
Drugs
sildenafil
03
Conditions
mitral stenosis (MS)pulmonary hypertension (PH)
Beyond the preview
Go deeper on IRCT2014072818625N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014072818625N1.